Sheets Smith Wealth Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-8,467
Closed -$934K 339
2019
Q1
$934K Hold
8,467
0.2% 131
2018
Q4
$779K Sell
8,467
-11
-0.1% -$1.11K 0.21% 125
2018
Q3
$934K Buy
8,478
+96
+1% +$9.99K 0.19% 133
2018
Q2
$783K Buy
8,382
+230
+3% +$19.8K 0.18% 132
2018
Q1
$676K Sell
8,152
-152
-2% -$13.5K 0.16% 153
2017
Q4
$756K Buy
8,304
+1,914
+30% +$159K 0.18% 148
2017
Q3
$487K Sell
6,390
-70
-1% -$5.29K 0.12% 187
2017
Q2
$485K Sell
6,460
-250
-4% -$17.3K 0.13% 174
2017
Q1
$438K Buy
+6,710
New +$395K 0.12% 191

Other funds holding PRAH

Sheets Smith Wealth Management's PRAH Position: Q2 2019 in Review

Sheets Smith Wealth Management sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2019, closing a stake of 8,467 shares — an estimated $934K sold.

Sheets Smith Wealth Management first reported a position in PRAH in Q1 2017 and held it in 9 quarters. The position peaked at $934K in Q1 2019. 329 funds tracked by Wall St. Rank hold PRAH as of Q2 2019.

  • Sheets Smith Wealth Management reported no remaining PRA Health Sciences, Inc. position as of Q2 2019 after selling out during the quarter.
  • Sheets Smith Wealth Management sold 8,467 PRA Health Sciences, Inc. shares in Q2 2019, an estimated $934K.
  • Sheets Smith Wealth Management first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 9 quarters.
  • Sheets Smith Wealth Management's PRA Health Sciences, Inc. position peaked at $934K in Q1 2019.
  • 329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2019.

Based on Sheets Smith Wealth Management's 13F filing for Q2 2019, filed 12 Jul 2019.